TREM2 and Alzheimer disease: TREM2 mutations carriers, among AD-affected individuals, present with a great amount of dystrophic microglia [213] compared to similar-AD-neuropathology-affected non-carrier people, suggesting a major vulnerability for senescent AD risk gene carrier microglia.